Company intelligence / Profile preview

Bioboost Synbio Inc.

Port Coquitlam, British Columbia, Canadamyemail-api.constantcontact.com ↗

Ownership: Private
Employees: ~6
Development stage: Other

Overview

Bioboost Synbio has developed a patented methanol-free Pichia pastoris fermentation technology to produce high-value recombinant proteins sustainably. The company secured patents in the US and Canada by 2022–2023 and commercialized its first molecule after two years of R&D. Five high-value proteins have been produced using their proprietary platform; however, there is no public information on clinical trial results or regulatory approvals for therapeutic use yet

Therapeutic areas: Other
Modalities: Recombinant proteinProteinMicrobial therapy (via yeast fermentation)Synthetic biology platform
Industry: Non-Drug Biotech

Beyond the preview

Go deeper on Bioboost Synbio Inc..

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Bioboost Synbio Inc..

Explore the full profile